Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Jingnan Yang
CONTACT
Lead
Beijing InnoCare Pharma Tech Co., Ltd.
This is an open label, randomized, multicenter phase 3 study for adult participants with relapsed/refractory marginal zone lymphoma (R/R MZL). The main goals are to compare complete response rate (CRR) and progression free survival (PFS) between the two treatment groups assessed by an Independent Review Committee (IRC).
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
